Theradiag S.A. buy krebskrebs
Start price
16.08.21
/
50%
€1.90
Target price
16.08.22
€2.40
Performance (%)
-14.53%
End price
17.08.22
€1.62
Summary
This prediction ended on 17.08.22 with a price of €1.62. The price of Theradiag S.A. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.53%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Theradiag S.A. | - | - | - | - |
| iShares Core DAX® | 0.463% | -1.999% | 9.981% | 58.545% |
| iShares Nasdaq 100 | -1.792% | -5.743% | -0.781% | 80.511% |
| iShares Nikkei 225® | 5.124% | 9.091% | 28.823% | 62.776% |
| iShares S&P 500 | -1.760% | -3.669% | -0.543% | 54.389% |
Comments by krebskrebs for this prediction
In the thread Theradiag S.A. diskutieren
In the thread Trading Theradiag S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten